| abstract |
As used herein, a combination therapy wherein a VEGF antagonist and a protein kinase inhibitor capable of at least inhibiting PDGF receptor tyrosine kinase are administered in a time and amount sufficient to treat or prevent a tumor in a subject. Disclosed are methods of using to treat tumors. |